Tolcapone, bromocriptine, and Parkinson's disease
暂无分享，去创建一个
A. Destée | Y. Agid | J. Montastruc | F. Durif | on behalf of the French Tolcapone Study Group P Pollak
[1] C. Adler,et al. Tolcapone Improves Motor Function and Reduces Levodopa Requirement in Patients with Parkinson's Disease Experiencing Motor Fluctuations , 1997, Neurology.
[2] T. Davis,et al. Acute effects of COMT inhibition on L-DOPA pharmacokinetics in patients treated with carbidopa and selegiline. , 1995, Clinical neuropharmacology.
[3] E. Tolosa,et al. New and emerging strategies for improving levodopa treatment. , 1994, Neurology.
[4] P. LeWitt. Treatment strategies for extension of levodopa effect. , 1992, Neurologic clinics.